The lack of <scp>anti‐PF4</scp> antibodies in convalescent plasma from <scp>COVID</scp>‐19 infected blood donor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor

Published:2023-03-30 Issue:3 Volume:33 Page:272-273
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Medicine

Author:

Piccin Andrea¹²³^ORCID,Mullin Barbara¹,Brown Alastair⁴,Benson Gary⁴

Affiliation:

1. Northern Ireland Blood Transfusion Service (NIBTS) Belfast UK

2. Department of Internal Medicine V Medical University of Innsbruck Innsbruck Austria

3. Department of Industrial Engineering University of Trento Trento Italy

4. Department of Haematology Belfast City Hospital Belfast UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.12965

Reference5 articles.

1. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination

2. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More

3. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review

4. Anti‐PF4 testing for vaccine‐induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide

5. Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-PF4 antibodies and their relationship with COVID infection;Hematology, Transfusion and Cell Therapy;2024-02

2. Overview of autoantibodies in COVID‐19 convalescents;Journal of Medical Virology;2023-06

3. Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis;Vaccines;2023-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3